| European Case Law Identifier: | ECLI:EP:BA:2023:T143622.20231127 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 27 November 2023 | ||||||||
| Case number: | T 1436/22 | ||||||||
| Application number: | 16731640.5 | ||||||||
| IPC class: | A61K 35/74 C12N 1/20 A61P 1/00 A61P 11/06 A61P 29/00 A61P 19/02 A61P 25/28 A61K 35/745 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | BLAUTIA STERCOSIS AND WEXLERAE FOR USE IN TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES | ||||||||
| Applicant name: | CJ Bioscience, Inc. | ||||||||
| Opponent name: | Hoffmann Eitle | ||||||||
| Board: | 3.3.07 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Basis of decision - text or agreement to text withdrawn by patent proprietor | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Summary of Facts and Submissions
I. The decision under appeal is the opposition division's decision rejecting the opposition filed against European patent No. 3 240 554.
II. The opponent (appellant) filed an appeal against the decision.
III. The proceedings were interrupted and resumed with a new patent proprietor (respondent).
IV. The board scheduled oral proceedings in line with the parties' requests.
V. In a letter dated 23 November 2023, the respondent wrote:
"The patentee hereby withdraws their approval of the text approved for grant.
Further, the patentee hereby withdraws requests presently on file.
We understand this terminates the Appeal proceedings and we look forward to confirmation that the proceedings are terminated."
Reasons for the Decision
1. With the letter dated 23 November 2023, the respondent withdrew its agreement to the text of the patent approved for grant and "requests presently on file". The latter expression does not explicitly refer to all the requests on file. However, the respondent understands that its withdrawals terminate the appeal proceedings and requests confirmation that the proceedings are terminated. Therefore, it can only be understood that the respondent's intention is to withdraw all its requests on file.
2. Under Article 113(2) EPC, the European Patent Office shall decide upon the European patent only in the text submitted to it, or agreed, by its proprietor.
3. By disapproving the text of the granted patent and withdrawing all amended text versions submitted to the EPO, the patent proprietor withdrew its approval of any text for maintenance of the patent. Therefore, there is no approved text of the patent on the basis of which the board can decide on the appeal.
4. In these circumstances, it is established case law that the patent must be revoked without further substantive examination as to patentability (see decision T 73/84, OJ EPO 1985, 241 and Case Law of the Boards of Appeal of the European Patent Office, 10th edition 2022, section IV.D.2). The board has no reason to deviate from this case law.
Order
For these reasons it is decided that:
The patent is revoked.
